3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasm Metastasis
8
Breast Neoplasms
8
Recurrence
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Treatment for Metastatic or Locally Advanced Cervical Cancer
1
Thyroid Neoplasms
1
Thymoma
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
Sorafenib
10
Magnetic Resonance Spectroscopy
10
trametinib
8
lenvatinib
8
dabrafenib
7
pembrolizumab
6
Nivolumab
6
Iodine-131
6
Everolimus
6
Sunitinib
5
Paclitaxel
5
vandetanib
4
apatinib
4
Thyrotropin Alfa
4
Doxorubicin
4
selpercatinib
3
anlotinib
3
Specimen Handling
3
Radiotherapy
3
Ipilimumab
3
Iodine-124
3
Fluorodeoxyglucose F18
3
Cisplatin
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
tislelizumab
2
tipifarnib
2
surufatinib
2
spartalizumab
2
pazopanib
2
omipalisib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Thyroid Neoplasms
×
NVP-BKM120
×
Clear all
NCT01830504
2016-10-05
BKM120
Hospices Civils de Lyon
Phase 2
Unknown
47 enrolled